- Indianapolis, Indiana
- Aarden Pharmaceuticals develops drugs targeting protein tyrosine phosphatases that catalyze the removal of phosphate groups.
- Thomas M. Estok, Christopher C. LeMasters, Zhong-Yin Zhang
- Pharmaceutical, Biotechnology
Aarden Pharmaceuticals is a small molecule drug discovery and development company. The company’s novel technology is a chemistry breakthrough that will enable it to make drugs against a previously un-druggable set of intracellular phosphatase (PTP) disease targets. The technology was developed in the laboratory of Dr. Zhong-Yin Zhang, Robert A. Harris Professor and chairman of biochemistry and molecular biology at the Indiana University School of Medicine. Zhang is an internationally recognized expert in the field of protein tyrosine phosphatases (PTPs). Aarden’s first programs are focused on infectious disease, cancer, and metabolic and autoimmune conditions.
Funding Rounds (1) - $500kUpdate
|Nov 27, 2013||SEC - SEC FORM D/A|
351 West 10th Street
Indianapolis, Indiana 46202